AlphaRose Therapeutics Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Early Stage VC
- Investors
-
3
AlphaRose Therapeutics General Information
Description
Developer of gene therapy targeting a mutation of the HNRNPH2 gene, intended to make rare disease gene therapies accessible to all. The company develops personalized genetic medicine such as antisense oligonucleotide (ASO) therapy, a tailored treatment solution for a small population of patients, enabling children to have rare genetic disorders to have access to affordable genetic treatments.
Contact Information
Website
www.alpharose.comCorporate Office
- 1401 Lavaca Street
- Suite 851
- Austin, TX 78701
- United States
Corporate Office
- 1401 Lavaca Street
- Suite 851
- Austin, TX 78701
- United States
AlphaRose Therapeutics Timeline
AlphaRose Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC | Completed | Generating Revenue | ||||
| 3. Equity Crowdfunding | 28-Jul-2025 | Completed | Generating Revenue | |||
| 2. Angel (individual) | 26-Nov-2024 | $2M | $2.1M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Jan-2024 | $100K | $100K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
AlphaRose Therapeutics Signals
AlphaRose Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Startup Warrior | Accelerator/Incubator | Minority | ||
| Advent Life Sciences | Venture Capital | Minority | ||
| Suncoast Ventures | Venture Capital | Minority |
AlphaRose Therapeutics Acquisitions (1)
AlphaRose Therapeutics’s most recent deal was a Merger/Acquisition with Alpha Anomeric. The deal was made on 29-Apr-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Alpha Anomeric | 29-Apr-2025 | Merger/Acquisition | Drug Discovery |
AlphaRose Therapeutics Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Alpha Anomeric | Paris, France | 2018 |
AlphaRose Therapeutics FAQs
-
When was AlphaRose Therapeutics founded?
AlphaRose Therapeutics was founded in 2023.
-
Where is AlphaRose Therapeutics headquartered?
AlphaRose Therapeutics is headquartered in Austin, TX.
-
What is the size of AlphaRose Therapeutics?
AlphaRose Therapeutics has 7 total employees.
-
What industry is AlphaRose Therapeutics in?
AlphaRose Therapeutics’s primary industry is Biotechnology.
-
Is AlphaRose Therapeutics a private or public company?
AlphaRose Therapeutics is a Private company.
-
What is AlphaRose Therapeutics’s current revenue?
The current revenue for AlphaRose Therapeutics is .
-
How much funding has AlphaRose Therapeutics raised over time?
AlphaRose Therapeutics has raised $3.7M.
-
Who are AlphaRose Therapeutics’s investors?
Startup Warrior, Advent Life Sciences, and Suncoast Ventures have invested in AlphaRose Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process